Study that will evaluate the Brazilian population with COPD.

Trial Identifier:	D5980R00117
Sponsor:	AstraZeneca
Start Date:	January 2025
Primary Completion Date:	February 2027
Study Completion Date:	February 2027

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
Brazil	Bahia, Brazil
Brazil	Belem, Brazil
Brazil	Brasilia, Brazil
Brazil	Campo Grande, Brazil
Brazil	Florianopolis, Brazil
Brazil	Santo Andre, Brazil
Brazil	Sao Paulo, Brazil
Brazil	Uberlandia, Brazil

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.